Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 99201-99250 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04656652
Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)
PHASE3
Active, not recruiting
605 participants
Started: Dec 21, 2020 · Completed: Jan 31, 2026
1 condition
2 sponsors
209 locations
NCT03997253
Optimizing Long-term Survival in Organ Transplantation: From Physiopathology to Optimized Patient Management
NA
Recruiting
430 participants
Started: Dec 21, 2020 · Completed: Nov 30, 2025
1 condition
2 sponsors
4 locations
NCT04665856
Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer
PHASE3
Active, not recruiting
123 participants
Started: Dec 21, 2020 · Completed: Jun 30, 2026
1 condition
1 sponsor
16 locations
NCT04331769
Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
NA
Recruiting
400 participants
Started: Dec 21, 2020 · Completed: Dec 21, 2030
2 conditions
1 sponsor
131 locations
NCT04669548
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
N/A
Recruiting
2,500 participants
Started: Dec 21, 2020 · Completed: Dec 31, 2026
4 conditions
1 sponsor
9 locations
NCT05106062
Economic and Clinical Benefit of Remote Monitoring Among Defibrillator Patients by Indication Subgroups (BENEFIT-RM)
NA
Recruiting
1,140 participants
Started: Dec 21, 2020 · Completed: Sep 30, 2029
1 condition
1 sponsor
1 location
NCT04663035
Ablation Plus Tislelizumab Versus Ablation Alone for Intrahepatic Recurrent Early Stage HCC
PHASE2
Recruiting
120 participants
Started: Dec 21, 2020 · Completed: Dec 18, 2025
1 condition
1 sponsor
1 location
NCT04625270
A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation
PHASE2
Active, not recruiting
225 participants
Started: Dec 21, 2020 · Completed: Dec 31, 2026
2 conditions
3 sponsors
47 locations
NCT04772196
Temporal Profile of Serum Vitamin D Levels in Foot and Ankle Fusion Surgery
EARLY_PHASE1
Enrolling by invitation
90 participants
Started: Dec 21, 2020 · Completed: Dec 31, 2025
2 conditions
2 sponsors
2 locations
NCT04250051
Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia
PHASE1
Active, not recruiting
2 participants
Started: Dec 21, 2020 · Completed: Dec 1, 2028
5 conditions
2 sponsors
1 location
NCT05061329
The Nasal Microbiome and Its Importance in Disease
N/A
Recruiting
619 participants
Started: Dec 21, 2020 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT05505513
Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Feedback?
NA
Recruiting
3 participants
Started: Dec 21, 2020 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04626635
A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
PHASE1/PHASE2
Recruiting
933 participants
Started: Dec 21, 2020 · Completed: Dec 12, 2026
1 condition
1 sponsor
50 locations
NCT04305795
An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors
PHASE1/PHASE2
Active, not recruiting
23 participants
Started: Dec 21, 2020 · Completed: Jun 30, 2027
4 conditions
1 sponsor
7 locations
NCT04257487
Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)
PHASE3
Recruiting
1,455 participants
Started: Dec 21, 2020 · Completed: Jan 2, 2027
3 conditions
1 sponsor
1 location
NCT04607421
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
PHASE3
Active, not recruiting
831 participants
Started: Dec 21, 2020 · Completed: Dec 28, 2027
1 condition
4 sponsors
268 locations
NCT04572230
International Post Market Surveillance Study of Intracranial Aneurysms Treated With an Endovascular Approach
N/A
Active, not recruiting
405 participants
Started: Dec 21, 2020 · Completed: Aug 31, 2025
1 condition
1 sponsor
32 locations
NCT04565015
Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
PHASE3
Active, not recruiting
24 participants
Started: Dec 21, 2020 · Completed: Nov 30, 2026
1 condition
2 sponsors
8 locations
NCT04624737
Intelligent Evaluation of Diabetic Retinopathy
N/A
Active, not recruiting
5,000 participants
Started: Dec 21, 2020 · Completed: Feb 21, 2025
1 condition
1 sponsor
14 locations
NCT04602533
Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)
PHASE2
Active, not recruiting
105 participants
Started: Dec 21, 2020 · Completed: Dec 31, 2026
1 condition
2 sponsors
16 locations
NCT07179081
A Study of AL58805 in Patients With Advanced Tumors
PHASE1
Recruiting
40 participants
Started: Dec 20, 2020 · Completed: Jan 26, 2026
1 condition
1 sponsor
1 location
NCT04604990
National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia
N/A
Recruiting
1,000 participants
Started: Dec 20, 2020 · Completed: Nov 1, 2050
1 condition
1 sponsor
1 location
NCT04994015
Parkinson's Foundation PD GENEration Genetic Registry
N/A
Recruiting
25,000 participants
Started: Dec 20, 2020 · Completed: Jul 1, 2026
1 condition
4 sponsors
56 locations
NCT04344717
Pharmacokinetics of Apixaban in Patients With Short Bowel Syndrome Requiring Long Term Parenteral Nutrition
PHASE4
Recruiting
84 participants
Started: Dec 20, 2020 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT04565119
Biomarkers in the Brain Oxygen Optimization in Severe Traumatic Brain Injury Trial
N/A
Recruiting
300 participants
Started: Dec 20, 2020 · Completed: Dec 31, 2027
1 condition
4 sponsors
2 locations
NCT04634240
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
NA
Recruiting
4,000 participants
Started: Dec 19, 2020 · Completed: Apr 1, 2026
3 conditions
1 sponsor
72 locations
NCT04407754
Myo-Inositol for Infertility in PCOS
NA
Recruiting
168 participants
Started: Dec 19, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04663308
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)
PHASE2
Active, not recruiting
182 participants
Started: Dec 18, 2020 · Completed: Apr 30, 2027
1 condition
1 sponsor
103 locations
NCT04721873
Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients
PHASE2
Recruiting
40 participants
Started: Dec 18, 2020 · Completed: Jun 30, 2024
2 conditions
1 sponsor
1 location
NCT05659524
Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery
NA
Recruiting
140 participants
Started: Dec 18, 2020 · Completed: Dec 31, 2029
1 condition
2 sponsors
2 locations
NCT05199532
Eosinophilic Gastrointestinal Disorders Registry
N/A
Recruiting
500 participants
Started: Dec 18, 2020 · Completed: Dec 31, 2035
4 conditions
1 sponsor
1 location
NCT04666740
A Study of Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based Therapy
PHASE2
Active, not recruiting
63 participants
Started: Dec 18, 2020 · Completed: Jan 31, 2026
2 conditions
2 sponsors
7 locations
NCT04171492
Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules
N/A
Active, not recruiting
2,000 participants
Started: Dec 18, 2020 · Completed: Dec 31, 2026
2 conditions
1 sponsor
25 locations
NCT05776771
The Spine Phenome Project
N/A
Recruiting
10,500 participants
Started: Dec 18, 2020 · Completed: Dec 31, 2030
2 conditions
3 sponsors
1 location
NCT04641442
Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations
PHASE2
Active, not recruiting
17 participants
Started: Dec 18, 2020 · Completed: Sep 11, 2027
1 condition
1 sponsor
21 locations
NCT04557969
Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
N/A
Recruiting
400 participants
Started: Dec 18, 2020 · Completed: Dec 30, 2040
5 conditions
1 sponsor
1 location
NCT04584255
Niraparib + Dostarlimab In BRCA Mutated Breast Cancer
PHASE2
Active, not recruiting
62 participants
Started: Dec 18, 2020 · Completed: Jul 17, 2029
8 conditions
4 sponsors
8 locations
NCT04916457
The Role of Skin Microecology in Diabetic Skin Lesions
N/A
Recruiting
200 participants
Started: Dec 18, 2020 · Completed: Jul 31, 2026
2 conditions
1 sponsor
1 location
NCT04665947
First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer
EARLY_PHASE1
Recruiting
30 participants
Started: Dec 18, 2020 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT04384692
Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis
PHASE2
Recruiting
60 participants
Started: Dec 18, 2020 · Completed: Dec 31, 2029
2 conditions
1 sponsor
1 location
NCT04640623
A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy
PHASE2
Active, not recruiting
220 participants
Started: Dec 18, 2020 · Completed: Jul 2, 2027
1 condition
1 sponsor
144 locations
NCT05049044
Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)
N/A
Active, not recruiting
413 participants
Started: Dec 18, 2020 · Completed: Jun 30, 2027
1 condition
2 sponsors
34 locations
NCT04705038
Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments
NA
Recruiting
100 participants
Started: Dec 18, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03721497
Testosterone in Bariatric Patients
PHASE4
Active, not recruiting
64 participants
Started: Dec 17, 2020 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT06324032
SUNNYDAY: SUbepithelialgastroiNtestiNal Tumors Detection,accuracYDiAgnosis,ElastographY and Contrast-enhanced EUS
N/A
Recruiting
138 participants
Started: Dec 17, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
7 locations
NCT04069624
Kentucky Women's Justice Community Opioid Innovation Network
NA
Active, not recruiting
900 participants
Started: Dec 17, 2020 · Completed: Apr 30, 2026
1 condition
2 sponsors
9 locations
NCT04430179
Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis
PHASE2
Active, not recruiting
30 participants
Started: Dec 17, 2020 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT04447352
HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT)
PHASE3
Recruiting
200 participants
Started: Dec 17, 2020 · Completed: May 1, 2027
2 conditions
2 sponsors
15 locations
NCT04319120
Pilot Study of Description of Cicatrisation Rates of Digital Ulcers in Systemic Scleroderma
N/A
Recruiting
78 participants
Started: Dec 17, 2020 · Completed: May 31, 2026
1 condition
1 sponsor
3 locations
NCT04700657
The Prevalence of Hypoesthesia Related Keratitis in Ocular Graft Vs. Host Disease (GVHD) Patients
N/A
Recruiting
30 participants
Started: Dec 17, 2020 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
Previous
1
More pages
1982
1983
1984
1985
1986
1987
1988
More pages
2369
Next